A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
This manuscript presents a protocol for establishing a mouse abdominal aortic aneurysm model using calcium chloride and elastase, combining the advantages of previous modeling methods. This model can be utilized to investigate the pathophysiological mechanisms underlying abdominal aortic aneurysms.
Abdominal aortic aneurysm (AAA) is a life-threatening disease associated with high mortality rates. It is characterized by the permanent dilation of the abdominal aorta with at least a 50% increase in arterial diameter. Various animal models of AAA have been introduced to mimic the pathophysiological changes and study the underlying mechanisms of AAA. Among these models, the calcium chloride (CaCl2)- and elastase-induced AAA models are commonly used in mice. However, these methods have certain limitations. Traditional intraluminal porcine pancreatic elastase (PPE) perfusion is associated with high technical difficulty and a high rupture rate, while periadventitial administration of PPE yields inconsistent results. In addition, the CaCl2-induced AAA model lacks human AAA features, such as atherothrombosis and aneurysm rupture. Therefore, the combined application of CaCl2 and PPE has been proposed as an approach to enhance success rates and induce greater diameter increases in AAA animal models. This manuscript presents a comprehensive protocol for establishing a mouse AAA model through periaortic infiltration of PPE and CaCl2 in the infrarenal segment of the abdominal aorta. By following this protocol, we can achieve an AAA formation rate of approximately 90% with technical simplicity and reproducibility. Further ultrasound and histological experiments confirm that this model effectively replicates the morphological and pathological changes observed in human AAA.
Abdominal aortic aneurysm (AAA) is defined as a diameter increase of more than 50% or a maximum aortic diameter exceeding 3 cm in the abdominal aorta. This condition poses a significant threat to life, with around a 90% mortality rate upon aneurysm rupture1,2,3. Currently, open surgical repair and endovascular aortic repair (EVAR) are the only available interventions for AAA patients4,5,6. However, there is insufficient evidence to support the effectiveness of medical treatments in i....
The animal experiment protocol complied with the National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH Pub No. 86/23, 1985) and was approved by the Institutional Animal Care and Use Committee of West China Hospital, Sichuan University (Approval Number 202311300012). Eight to ten-week-old C57/B6J male mice were used for this study. The details of the reagents and equipment used are listed in the Table of Materials.
1. Preoperative preparation<.......
In this study, a total of 24 mice were included and randomly assigned: 12 in the Sham group and 12 in the PPE + CaCl2 group, respectively. All data are presented as means ± standard deviations unless otherwise stated. The average operation time was 55.67 min ± 4.08 min. There were no intra-operative deaths or aneurysm ruptures, and the survival rate within 21 days after surgery was 100%. No severe intestinal adhesions or complications related to abdominal aorta dissection were observed.
Research into the molecular mechanisms of AAA requires a stable animal model. Consequently, numerous AAA animal models have been established since its initial development by Economou et al. in the 1960s29. Among these models, CaCl2 is frequently employed in rodents due to its cost-effectiveness, technical simplicity, and reliable reproducibility. However, perivascular CaCl2 infiltration has been shown to be unstable in establishing AAA. Bi et al. and Freestone et al. reported.......
This work was supported by the National Natural Science Foundations of China (No. 82300542, 81770471), Sichuan Science and Technology Program (No. 2022YFS0359, 2019JDRC0104) and Post-Doctor Research Project, West China Hospital, Sichuan University (No. 2023HXBH108). The funding bodies played no role in the design of the study, the collection, analysis, and interpretation of the data, and the writing of the manuscript.
....Name | Company | Catalog Number | Comments |
Anesthesia Machine | RWD | R550 | |
Butorphanol | Jiangsu Hengrui Pharmaceutical Co., Ltd | 220608BP | 1ml: 1mg |
C57BL/6JGpt Male Mice | GemPharmatech | N000013 | |
Calcium Chloride | Sigma Aldrich | C4901 | 100 g |
Carprofen | MCE | HY-B1227 | 100 mg |
Chow Diet | Dossy Experimental Animals Co.Ltd | ||
Digital Caliper | Greener | IP54 | |
Ethanol | Jinhe Pharmaceutical Co.Ltd | 539682 | 75%/500 mL |
EVG Staining Kit | Solarbio | G1597 | |
GraphPad Prism | Graphpad | Ver 9.0.0 | |
H&E Staining Kit | Servicebio | G1076 | |
Insulin Syringe | BD | 2143420 | |
Isoflurane | RWD | R510-22-4 | 100 mL |
Masson Staining Kit | Servicebio | G1006 | |
Normal Saline | Servicebio | G4702 | 500 mL |
Paraformaldehyde | Biosharp | BL539A | 4%/500 mL |
PBS, 1x | Servicebio | G4202 | 500 mL |
Porcine Pancreatic Elastase | Sigma Aldrich | E1250 | 100 mg |
Povidine Iodine | Yongan Pharmaceutical Co.Ltd | 5%/100 mg | |
Prolene Polypropylene Suture | Ethicon LLC | 8709H | |
Rodent Ultrasound System | Fujifilm | Vevo 3100LT | |
Stereo Microscope | Olympus | SZ61 | |
Ultrasonic Couplant | Keppler | KL-250 | 250 g |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved